[SCHEDULE 13G/A] Immunic, Inc. SEC Filing
Adage Capital Management, L.P., together with Robert Atchinson and Phillip Gross, reports beneficial ownership of 10,479,337 shares of Immunic, Inc. (IMUX), representing 9.99% of the outstanding common stock. The filing states this total includes 9,080,737 shares issuable upon exercise of warrants and that the percentage is calculated on an aggregate base of 95,817,536 shares outstanding as reported in the company prospectus.
The reporting persons disclose no sole voting or dispositive power and instead report shared voting and shared dispositive power for the reported shares. The filing also certifies the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.
Adage Capital Management, L.P., insieme a Robert Atchinson e Phillip Gross, dichiara la titolarit脿 beneficiaria di 10,479,337 azioni di Immunic, Inc. (IMUX), pari al 9.99% del capitale sociale ordinario in circolazione. La comunicazione specifica che questo totale comprende 9,080,737 azioni emettibili in caso di esercizio di warrant e che la percentuale 猫 calcolata su una base aggregata di 95,817,536 azioni in circolazione come riportato nel prospetto societario.
Le persone che presentano la comunicazione dichiarano di avere nessun potere di voto o dispositivo esclusivo e segnalano invece poteri di voto condivisi e poteri dispositivi condivisi per le azioni indicate. Il deposito certifica inoltre che i titoli sono detenuti nell'ordinario corso dell'attivit脿 e non allo scopo di modificare o influenzare il controllo.
Adage Capital Management, L.P., junto con Robert Atchinson y Phillip Gross, informa la propiedad beneficiaria de 10,479,337 acciones de Immunic, Inc. (IMUX), que representan el 9.99% del capital social ordinario en circulaci贸n. La presentaci贸n indica que este total incluye 9,080,737 acciones susceptibles de emitirse por el ejercicio de warrants y que el porcentaje se calcula sobre una base agregada de 95,817,536 acciones en circulaci贸n seg煤n consta en el prospecto de la compa帽铆a.
Las personas informantes declaran no tener poder exclusivo de voto o disposici贸n y, en su lugar, reportan poder de voto compartido y poder de disposici贸n compartido sobre las acciones notificadas. La presentaci贸n tambi茅n certifica que los valores se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control.
Adage Capital Management, L.P.電� Robert Atchinson 氚� Phillip Gross鞕� 頃粯 Immunic, Inc.(IMUX)鞚� 氤错喌欤� 10,479,337欤�, 歃� 氚滍枆欤检嫕鞚� 9.99%鞐� 雽�頃� 鞁れ鞝� 靻岇湢毳� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊電� 鞚� 齑濌硠臧� 鞗岆煱韸� 頄夓偓搿� 氚滍枆 臧�電ロ暅 9,080,737欤茧ゼ 韽暔頃滊嫟瓿� 氚濏瀳氅�, 鞚� 牍勳湪鞚� 須岇偓 鞎堧偞靹滌棎 旮办灛霅� 雽�搿� 齑� 95,817,536欤检潣 氚滍枆欤检嫕鞚� 旮办鞙茧 瓿勳偘霅橃棃雼り碃 氇呾嫓頃╇媹雼�.
氤搓碃鞚鸽摛鞚赌 雼弲鞚� 鞚橁舶甓� 霕愲姅 觳橂秳甓岇澊 鞐嗢潓鞚� 瓿奠嫓頃橁碃 雽�鞁� 氤搓碃霅� 欤检嫕鞐� 雽�頃� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓岇潉 氤搓碃頃╇媹雼�. 頃措嫻 鞝滌稖靹滊電� 霕愴暅 歃濌秾鞚� 鞓侅梾鞚� 韱奠儊鞝� 瓿检爼鞐愳劀 氤挫湢霅橁碃 鞛堨溂氅� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 氤挫湢霅橃 鞎婌晿鞚岇潉 歃濍獏頃╇媹雼�.
Adage Capital Management, L.P., conjointement avec Robert Atchinson et Phillip Gross, d茅clare d茅tenir la propri茅t茅 b茅n茅ficiaire de 10,479,337 actions d'Immunic, Inc. (IMUX), soit 9.99% des actions ordinaires en circulation. Le d茅p么t indique que ce total comprend 9,080,737 actions pouvant 锚tre 茅mises 脿 l'exercice de warrants et que le pourcentage est calcul茅 sur une base agr茅g茅e de 95,817,536 actions en circulation, comme indiqu茅 dans le prospectus de la soci茅t茅.
Les personnes d茅clarantes pr茅cisent qu'elles n'ont aucun pouvoir de vote ou de disposition exclusif et d茅clarent plut么t disposer d'un pouvoir de vote partag茅 et d'un pouvoir de disposition partag茅 pour les actions d茅clar茅es. Le d茅p么t certifie 茅galement que les titres sont d茅tenus dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le.
Adage Capital Management, L.P., zusammen mit Robert Atchinson und Phillip Gross, meldet wirtschaftliches Eigentum an 10,479,337 Aktien von Immunic, Inc. (IMUX), was 9.99% des ausstehenden Stammkapitals entspricht. Die Einreichung gibt an, dass diese Summe 9,080,737 Aktien umfasst, die bei Aus眉bung von Warrants ausgebbar sind, und dass der Prozentsatz auf einer aggregierten Basis von 95,817,536 ausstehenden Aktien berechnet wird, wie im Unternehmensprospekt angegeben.
Die meldenden Personen geben an, keine alleinige Stimm- oder Verf眉gungsgewalt zu besitzen und stattdessen 眉ber gemeinsame Stimmrechte und gemeinsame Verf眉gungsgewalt f眉r die gemeldeten Aktien zu verf眉gen. Die Einreichung best盲tigt au脽erdem, dass die Wertpapiere im normalen Gesch盲ftsverlauf gehalten werden und nicht zum Zweck der Ver盲nderung oder Beeinflussung der Kontrolle.
- Beneficial ownership of 10,479,337 shares representing 9.99% of the class as reported.
- Includes 9,080,737 shares issuable upon exercise of warrants, disclosed transparently in the filing.
- Reporting architecture clearly identified (Adage Capital Management, L.P., Robert Atchinson, Phillip Gross).
- No sole voting or dispositive power reported; all authority is listed as shared.
- Position is 9.99%, which is just below the 10% mark used as a regulatory threshold in many contexts.
- Reported stake relies heavily on warrants, which affects actual current ownership and potential dilution dynamics.
Insights
TL;DR: Adage reports a sizeable 9.99% economic stake in Immunic, largely driven by warrant exercise, with only shared voting power.
The filing discloses a 10,479,337-share position representing 9.99% of the class based on an outstanding-share base of 95,817,536 and explicitly includes 9,080,737 shares issuable upon exercise of warrants held by Adage structures. Because the reported position is comprised primarily of warrant-derived shares and is reported as shared voting/dispositive power with 0 sole power, this is material from a disclosure perspective but does not signal unilateral control. Investors should note the stake size and warrant exposure when assessing potential dilution and influence.
TL;DR: The disclosure shows significant economic exposure but no sole control; governance influence appears shared.
The filing names Adage Capital Management, L.P., Robert Atchinson and Phillip Gross as reporting persons and documents that all voting and dispositive authority over the 10,479,337 shares is shared rather than sole. The inclusion of 9,080,737 warrant-issuable shares in the reported total is explicitly noted and the ownership percentage is calculated assuming exercise. From a governance standpoint, the position is meaningful but the absence of sole voting power indicates limited unilateral governance control based on the disclosed facts.
Adage Capital Management, L.P., insieme a Robert Atchinson e Phillip Gross, dichiara la titolarit脿 beneficiaria di 10,479,337 azioni di Immunic, Inc. (IMUX), pari al 9.99% del capitale sociale ordinario in circolazione. La comunicazione specifica che questo totale comprende 9,080,737 azioni emettibili in caso di esercizio di warrant e che la percentuale 猫 calcolata su una base aggregata di 95,817,536 azioni in circolazione come riportato nel prospetto societario.
Le persone che presentano la comunicazione dichiarano di avere nessun potere di voto o dispositivo esclusivo e segnalano invece poteri di voto condivisi e poteri dispositivi condivisi per le azioni indicate. Il deposito certifica inoltre che i titoli sono detenuti nell'ordinario corso dell'attivit脿 e non allo scopo di modificare o influenzare il controllo.
Adage Capital Management, L.P., junto con Robert Atchinson y Phillip Gross, informa la propiedad beneficiaria de 10,479,337 acciones de Immunic, Inc. (IMUX), que representan el 9.99% del capital social ordinario en circulaci贸n. La presentaci贸n indica que este total incluye 9,080,737 acciones susceptibles de emitirse por el ejercicio de warrants y que el porcentaje se calcula sobre una base agregada de 95,817,536 acciones en circulaci贸n seg煤n consta en el prospecto de la compa帽铆a.
Las personas informantes declaran no tener poder exclusivo de voto o disposici贸n y, en su lugar, reportan poder de voto compartido y poder de disposici贸n compartido sobre las acciones notificadas. La presentaci贸n tambi茅n certifica que los valores se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control.
Adage Capital Management, L.P.電� Robert Atchinson 氚� Phillip Gross鞕� 頃粯 Immunic, Inc.(IMUX)鞚� 氤错喌欤� 10,479,337欤�, 歃� 氚滍枆欤检嫕鞚� 9.99%鞐� 雽�頃� 鞁れ鞝� 靻岇湢毳� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊電� 鞚� 齑濌硠臧� 鞗岆煱韸� 頄夓偓搿� 氚滍枆 臧�電ロ暅 9,080,737欤茧ゼ 韽暔頃滊嫟瓿� 氚濏瀳氅�, 鞚� 牍勳湪鞚� 須岇偓 鞎堧偞靹滌棎 旮办灛霅� 雽�搿� 齑� 95,817,536欤检潣 氚滍枆欤检嫕鞚� 旮办鞙茧 瓿勳偘霅橃棃雼り碃 氇呾嫓頃╇媹雼�.
氤搓碃鞚鸽摛鞚赌 雼弲鞚� 鞚橁舶甓� 霕愲姅 觳橂秳甓岇澊 鞐嗢潓鞚� 瓿奠嫓頃橁碃 雽�鞁� 氤搓碃霅� 欤检嫕鞐� 雽�頃� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓岇潉 氤搓碃頃╇媹雼�. 頃措嫻 鞝滌稖靹滊電� 霕愴暅 歃濌秾鞚� 鞓侅梾鞚� 韱奠儊鞝� 瓿检爼鞐愳劀 氤挫湢霅橁碃 鞛堨溂氅� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 氤挫湢霅橃 鞎婌晿鞚岇潉 歃濍獏頃╇媹雼�.
Adage Capital Management, L.P., conjointement avec Robert Atchinson et Phillip Gross, d茅clare d茅tenir la propri茅t茅 b茅n茅ficiaire de 10,479,337 actions d'Immunic, Inc. (IMUX), soit 9.99% des actions ordinaires en circulation. Le d茅p么t indique que ce total comprend 9,080,737 actions pouvant 锚tre 茅mises 脿 l'exercice de warrants et que le pourcentage est calcul茅 sur une base agr茅g茅e de 95,817,536 actions en circulation, comme indiqu茅 dans le prospectus de la soci茅t茅.
Les personnes d茅clarantes pr茅cisent qu'elles n'ont aucun pouvoir de vote ou de disposition exclusif et d茅clarent plut么t disposer d'un pouvoir de vote partag茅 et d'un pouvoir de disposition partag茅 pour les actions d茅clar茅es. Le d茅p么t certifie 茅galement que les titres sont d茅tenus dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le.
Adage Capital Management, L.P., zusammen mit Robert Atchinson und Phillip Gross, meldet wirtschaftliches Eigentum an 10,479,337 Aktien von Immunic, Inc. (IMUX), was 9.99% des ausstehenden Stammkapitals entspricht. Die Einreichung gibt an, dass diese Summe 9,080,737 Aktien umfasst, die bei Aus眉bung von Warrants ausgebbar sind, und dass der Prozentsatz auf einer aggregierten Basis von 95,817,536 ausstehenden Aktien berechnet wird, wie im Unternehmensprospekt angegeben.
Die meldenden Personen geben an, keine alleinige Stimm- oder Verf眉gungsgewalt zu besitzen und stattdessen 眉ber gemeinsame Stimmrechte und gemeinsame Verf眉gungsgewalt f眉r die gemeldeten Aktien zu verf眉gen. Die Einreichung best盲tigt au脽erdem, dass die Wertpapiere im normalen Gesch盲ftsverlauf gehalten werden und nicht zum Zweck der Ver盲nderung oder Beeinflussung der Kontrolle.
FAQ
What stake does Adage Capital report in Immunic (IMUX)?
How many of the reported shares are from warrants?
Does Adage have sole voting or dispositive control over the reported IMUX shares?
On what outstanding-share base is the percentage calculated?
Who are the reporting persons named in the Schedule 13G/A for IMUX?
